Source: CNBC
Summary
The new Medicare pilot program, Bridge, allows Americans to access GLP-1 medications for only $50 a month. This initiative aims to improve diabetes management and weight loss for millions on Medicare.
Why It Matters
This program offers essential access to costly medications needed for chronic conditions like diabetes, significantly easing the financial burden on seniors. By making GLP-1s more affordable, it could lead to better health outcomes and overall quality of life for those dependent on these medications.




